Wegovy Alternatives
People look for Wegovy alternatives for four different reasons, and the right answer depends entirely on which one applies to you: cost, supply, side effects, or the injection itself. Below is every real option with what it actually costs — and one important update, which is that "Wegovy is too expensive" is a much weaker reason than it was a year ago.
Start here: is cost actually the problem?
Wegovy's reputation for costing $1,300 a month is out of date. Novo Nordisk now sells it direct through NovoCare Pharmacy at $149 a month for the pill and $199 for the pen, with free home delivery and no membership. If you have commercial insurance that covers GLP-1 medicines, its savings offer can bring that to as little as $25 a month for up to three months, and eligible Medicare patients pay $50 a month through the Medicare GLP-1 Bridge program.
That means a large share of people searching for a cheaper alternative to Wegovy should simply buy Wegovy differently. Before switching molecules, price the direct route.
Every alternative, compared
Zepbound (tirzepatide)
FDA-approved, different molecule$299–$449/mo self-pay via LillyDirect
The strongest therapeutic alternative. Tirzepatide activates both GIP and GLP-1 receptors and produced greater average weight loss than semaglutide in the SURMOUNT-5 head-to-head trial. Priced competitively direct from Eli Lilly.
LillyDirect review →Wegovy pill (oral semaglutide)
FDA-approved, same moleculeFrom $149/mo; as little as $25 with commercial coverage
Same active ingredient, no injection. If your objection to Wegovy is the needle or the price rather than the drug, this solves both — it is the cheapest FDA-approved semaglutide route available.
NovoCare Pharmacy review →Ozempic (semaglutide)
FDA-approved, same moleculeFrom $149/mo pill, $199/mo pen
Identical active ingredient from the same manufacturer, approved for type 2 diabetes rather than weight management. Prescribing decisions depend on your diagnosis, but the pricing through NovoCare matches Wegovy.
NovoCare Pharmacy review →Foundayo (orforglipron)
FDA-approved, newer oral GLP-1From $149/mo self-pay; as little as ~$25 with savings offers
A newer small-molecule oral GLP-1 from Eli Lilly. Because it is not a peptide it avoids the food and water timing restrictions of earlier oral semaglutide.
Oral GLP-1 providers →Saxenda (liraglutide)
FDA-approved, older GLP-1Varies; a generic liraglutide has been approved
A daily rather than weekly injection and generally less effective than semaglutide, but the availability of an approved generic liraglutide can make it substantially cheaper.
Providers that prescribe it →Contrave (naltrexone-bupropion)
FDA-approved, non-GLP-1 oralVaries by provider and coverage
A completely different mechanism, taken as a pill. Relevant if GLP-1s are contraindicated for you or you cannot tolerate the gastrointestinal side effects.
Form Health review →Compounded semaglutide
Not FDA-approved$70–$299/mo plus any membership fee
The same active molecule prepared by a compounding pharmacy. Cheapest on paper, but the FDA does not review these products for safety, effectiveness or quality, and availability has been unstable since the shortage ended.
Best compounded providers →Compounded tirzepatide
Not FDA-approved$100–$545/mo plus any membership fee
A cheaper route to the tirzepatide molecule at low doses. At higher doses, FDA-approved Zepbound at a flat $449 is often cheaper as well as approved.
Best tirzepatide providers →Choosing by reason
- If cost is the problem
- Buy Wegovy direct at $149–$199/mo, or check whether your plan covers it and get prior authorization handled for you. Only then consider compounded semaglutide.
- If results are the problem
- Zepbound is the evidence-backed step up — tirzepatide produced greater average weight loss than semaglutide in the SURMOUNT-5 head-to-head trial. See semaglutide vs. tirzepatide.
- If the injection is the problem
- The Wegovy pill or Foundayo, both FDA-approved orals from $149/mo. Compounded sublingual options exist from about $164 per 4-week supply — see oral and needle-free providers.
- If side effects are the problem
- Talk to your prescriber before switching — dose adjustment or a slower titration often resolves gastrointestinal effects, and tirzepatide shares the same profile. Contrave is a genuinely different mechanism if GLP-1s do not suit you. See managing GLP-1 side effects.
- If you do not qualify
- Read our eligibility guide. If a contraindication is the reason, that applies to the whole GLP-1 class — not just Wegovy — and a non-GLP-1 option is the right conversation to have.
Frequently asked questions
What is the closest alternative to Wegovy?
Ozempic is the same active ingredient from the same manufacturer, approved for type 2 diabetes rather than weight management. For weight loss specifically, Zepbound is the closest therapeutic alternative and outperformed semaglutide in the SURMOUNT-5 head-to-head trial.
Is compounded semaglutide the same as Wegovy?
No. It contains the same active molecule but is not an FDA-approved finished drug product, and the FDA does not review it for safety, effectiveness or quality. Compounded formulations often add ingredients such as B12 or glycine that are not in Wegovy.
Can I switch from Wegovy to Zepbound?
Yes, and it is common. Because the two drugs use different dosing scales you generally restart titration on the new medication rather than converting your dose across. Your prescriber should manage this.
What if I stop taking it altogether?
Weight regain after stopping is well documented across this drug class. Obesity is treated as a chronic condition, so any decision to stop rather than switch is worth discussing with a clinician who can plan for it.
Where to go next
Medical disclaimer
This article is general information, not medical advice, and it is not a recommendation to switch or stop any medication. Only a licensed healthcare professional who knows your medical history can decide which treatment is appropriate for you. GLP-1 medications carry a boxed warning regarding thyroid C-cell tumors and other serious potential risks. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Pricing changes frequently — verify current rates directly.
Date reviewed: August 3, 2026